Shuttle Pharmaceuticals Faces Delisting Concerns
Ticker: SHPH · Form: 8-K · Filed: Nov 17, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Nov 17, 2025 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00001, $1,394,161, $2,500,000, $2.5 m |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rule-violation, regulatory-filing
TL;DR
Shuttle Pharma might get kicked off the exchange - big trouble.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on November 17, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates potential issues with the company's continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade publicly, posing a significant risk to its operations and investors.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- November 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Address of principal executive offices
FAQ
What specific listing rule or standard has Shuttle Pharmaceuticals Holdings, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is November 17, 2025.
In which state is Shuttle Pharmaceuticals Holdings, Inc. incorporated?
Shuttle Pharmaceuticals Holdings, Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the company's telephone number?
The registrant's telephone number, including area code, is (240) 430-4212.
Filing Stats: 851 words · 3 min read · ~3 pages · Grade level 15.8 · Accepted 2025-11-17 16:05:50
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
- $1,394,161 — pany") reported stockholders' equity of $1,394,161 in its Quarterly Report on Form 10-Q fo
- $2,500,000 — ket ("Nasdaq") to maintain a minimum of $2,500,000 in stockholders' equity for continued l
- $2.5 m — gregate gross proceeds of approximately $2.5 million, before deducting placement agent
Filing Documents
- form8-k.htm (8-K) — 38KB
- 0001493152-25-023845.txt ( ) — 202KB
- shph-20251117.xsd (EX-101.SCH) — 3KB
- shph-20251117_lab.xml (EX-101.LAB) — 33KB
- shph-20251117_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Date: November 17, 2025 By: /s/ Christopher Cooper Christopher Cooper Interim Chief Executive Officer